Myasthenia gravis constitutes chronic autoimmune ailment that primarily targets the neuromuscular junction. This junction facilitates the transfer of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system mistakenly attacks these receptors, resulting weakness and fatigue in the muscles. The manifestations